PMC full text: | Published online 2018 Aug 28. doi: 10.1186/s12935-018-0619-7
|
No. | Age | Sex | Location | T | N | M | Differentiation |
---|---|---|---|---|---|---|---|
1 | 59 | M | Gingiva | 1 | 0 | 0 | Well |
2 | 69 | F | Buccal | 2 | 0 | 0 | Well |
3 | 64 | F | Buccal | 2 | 0 | 0 | Well |
4 | 61 | M | Palate | 2 | 0 | 0 | Poor |
5 | 65 | M | Gingiva | 3 | 0 | 0 | Moderate |
6 | 72 | M | Buccal | 2 | 0 | 0 | Moderate |
7 | 60 | M | Oropharynx | 2 | 0 | 0 | Moderate |
8 | 59 | M | Palate | 2 | 0 | 0 | Well |
9 | 64 | F | Gingiva | 4a | 0 | 0 | Poor |
10 | 65 | M | Buccal | 2 | 0 | 0 | Moderate |
11 | 38 | F | Tongue | 2 | 0 | 0 | Moderate |
12 | 60 | M | Tongue | 4a | 0 | 0 | Poor |
13 | 67 | F | Tongue | 4a | 0 | 0 | Moderate |
14 | 79 | F | Palate | 4a | 0 | 0 | Poor |
15 | 49 | F | Gingiva | 3 | 0 | 0 | Poor |
16 | 43 | M | Gingiva | 4a | 0 | 0 | Moderate |
17 | 61 | M | Buccal | 2 | 0 | 0 | Poor |
18 | 54 | M | Tongue | 1 | 0 | 0 | Moderate to well |
19 | 81 | M | Tongue | 2 | 0 | 0 | Moderate |
20 | 68 | F | Buccal | 1 | 0 | 0 | Moderate |
21 | 50 | M | Gingiva | 2 | 1 | 0 | Moderate |
22 | 67 | M | Buccal | 2 | 1 | 0 | Moderate |
23 | 63 | M | Tongue | 3 | 1 | 0 | Poor |
24 | 66 | M | Gingiva | 4 | 2a | 0 | Poor |
25 | 50 | F | Tongue | 2 | 1 | 0 | Poor |
26 | 78 | F | Tongue | 1 | 2b | 0 | Moderate |
27 | 56 | M | Buccal | 2 | 1 | 0 | Well |
28 | 66 | M | Tongue | 3 | 2c | 0 | Well |
29 | 54 | F | Buccal | 4a | 2b | 0 | Well |
30 | 56 | M | Gingiva | 4a | 2b | 0 | Poor |
31 | 78 | M | Buccal | 3 | 2b | 0 | Well |
32 | 69 | M | Gingiva | 2 | 2b | 0 | Poor |
33 | 68 | F | Buccal | 3 | 1 | 0 | Moderate |
34 | 74 | F | Buccal | 4a | 2a | 0 | Moderate |
35 | 57 | M | Tongue | 4a | 1 | 0 | Poor |
36 | 67 | M | Gingiva | 4a | 1 | 0 | Moderate |
37 | 54 | F | Gingiva | 4a | 1 | 0 | Moderate |
38 | 72 | M | Gingiva | 3 | 1 | 0 | Moderate |
39 | 74 | F | Gingiva | 2 | 1 | 0 | Poor |
40 | 71 | F | Tongue | 3 | 1 | 0 | Moderate |
HNSCC head and neck squamous cell carcinoma, F female, M male; TNM classification and tumor stage were determined by the Union for International Cancer Control (UICC); HNSCC without metastatic primary tumors (No. 1–20); HNSCC with associated regional nodal metastases (No. 21–40)